Authors: Nived, O Bengtsson, A Jonsen, A Sturfelt, G Olsson, H

Citation: O. Nived et al., Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden, LUPUS, 10(7), 2001, pp. 500-504

Authors: Sturfelt, G Bengtsson, A Klint, C Nived, O Sjoholm, A Truedsson, L

Citation: G. Sturfelt et al., Novel roles of complement in systemic lupus erythematosus - Hypothesis fora pathogenetic vicious circle, J RHEUMATOL, 27(3), 2000, pp. 661-663

Authors: Stahl-Hallengren, C Jonsen, A Nived, O Sturfelt, G

Citation: C. Stahl-hallengren et al., Incidence studies of systemic lupus erythematosus in Southern Sweden: Increasing age, decreasing frequency of renal manifestations and good prognosis, J RHEUMATOL, 27(3), 2000, pp. 685-691

Authors: Gladman, DD Goldsmith, CH Urowitz, MB Bacon, P Fortin, P Ginzler, E Gordon, C Hanly, JG Isenberg, DA Petri, M Nived, O Snaith, M Sturfelt, G

Citation: Dd. Gladman et al., The Systemic Lupus International Collaborating Clinics/American College ofRheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison, J RHEUMATOL, 27(2), 2000, pp. 373-376

Authors: Blomqvist, P Haglund, U Knutson, K Lundborg, G Marke, LA Nived, O Rydholm, U Sollerman, C Svensson, B Hafstrom, I Johansson, S Nilsson, O Sjoden, G

Citation: P. Blomqvist et al., Untitled - Introduction, ACT ORTH SC, 71, 2000, pp. NIL_3

Authors: Tjernstrom, F Hellmer, G Nived, O Truedsson, L Sturfelt, G

Citation: F. Tjernstrom et al., Synergetic effect between interleukin-l receptor antagonist allele (IL1RN2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus, LUPUS, 8(2), 1999, pp. 103-108